New MRI contrast agent tested on big animals

Experiments in dogs, rabbits and monkeys show the efficacy and biocompatibility of a new MRI/MRA contrast agent in detecting stroke. This T1 MRI contrast agent based on ultrasmall iron oxide nanoparticles could become a possible alternative to clinically used gadolinium-based agents.